[1] Litwin MS. and Tan HJ. The Diagnosis and Treatment of Prostate Cancer: A Review[J]. JAMA, 2017, 317(24): 2532-2542.
[2] Gosselaar C, Roobol MJ, Roemeling S, et al. The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer[J]. BJU international, 2008, 101(6):685-690.
[3] Han M, Chang D, Kim C, et al. Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy[J]. Journal of Urology, 2012, 88(6):2404-2409.
[4] Gayet M, van der Aa A, Beerlage HP, et al. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review[J]. BJU Int, 2016, 117(3):392-400.
[5]Tempany CM, Turkbey B, Rosenkrantz AB. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer[J]. Radiology, 2017, 285(2):343-356.
[6] Smeenge M, Tranquart F, Mannaerts C K, et al. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer[J]. Investigative Radiology, 2017, 52(7):419-427.
[7] Fanti S and Minozzi S, Antoch G, et al. Consensus on molecular imaging and theranostics in prostate cancer[J]. The Lancet Oncology, 2019, 19(12): e696-e708.
[8] Wang LV. Multiscale photoacoustic microscopy and computed tomography[J]. Nat Photonics, 2009, 3(9):503-509.
[9] Sheng W, Jing L, Tianfu W, et al. Recent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications[J]. Theranostics, 2016, 6(13):2394-2413.
[10] Stoffels I. and Morscher S, Helfrich I, et al. Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging[J]. Science Translational Medicine, 2015, 7(317): 317ra199.
[11] Xu M, Wang LV. Photoacoustic imaging in biomedicine[J]. Review of Scientific Instruments, 2006, 77(4):41101-0.
[12] Jelena L, Ataya S, Gambhir S S. A high-affinity, high-stability photoacoustic agent for imaging gastrin-releasing peptide receptor in prostate cancer[J]. Clinical Cancer Research, 2014, 20(14):3721-9.
[13] Zhang HK, Chen Y, Kang J, et al. Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo[J]. J Biophotonics, 2018, Sep;11(9):e201800021.
[14] Dijkstra BM. and Jeltema HJ, Kruijff S, et al. (2018). The application of fluorescence techniques in meningioma surgery—a review[J]. Neurosurgical Review, 2019, 42(4):799-809.
[15] Zheng C, Zheng M, Gong P, et al. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging[J]. Biomaterials, 2012, 33(22):5603-5609.
[16] Wang H, Liu C, Gong X, et al. In vivo photoacoustic molecular imaging of breast carcinoma with folate receptor-targeted indocyanine green nanoprobes.[J]. Nanoscale, 2014, 6(23):14270-14279.
[17] Desgrosellier J S, Cheresh D A. Integrins in cancer: biological implications and therapeutic opportunities[J]. Nature Reviews Cancer, 2010, 10(1):9.
[18] Sipkins D A, Cheresh D A, Kazemi M R, et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging[J]. Nature Medicine, 1998, 4(5):623-626.
[19] Beer A J, Haubner R, Sarbia M, et al. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man. Clin Cancer Res[J]. Clinical Cancer Research, 2006, 12(13):3942.
[20] Li M , Liu C, Gong X , et al. Linear array-based real-time photoacoustic imaging system with a compact coaxial excitation handheld probe for noninvasive sentinel lymph node mapping[J]. Biomedical Optics Express, 2018, 9(4):1408-1422.
[21] Bai Y, Cong B, Gong X, et al. Compact and low-cost handheld quasibright-field linear-array probe design in photoacoustic computed tomography[J]. J Biomed Opt. 2018, 23(12):1-10.
[22] Kim J, Park S, Jung Y, et al. Programmable Real-time Clinical Photoacoustic and Ultrasound Imaging System[J]. Scientific Reports, 2016, 6:35137.
[23] Ni J, Cozzi P, Hung T T, et al. Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique[J]. Translational Oncology, 2016, 9(1):41-45.